Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Completed

Evaluation of Lasofoxifene Combined With Abemaciclib in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

NCT04432454

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • University of Alabama at Birmingham (UAB) - Comprehensive Cancer Center Birmingham, Alabama, United States
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • Compassionate Cancer Care Med Group - Clinic Aid USA - Fountain Valley Fountain Valley, California, United States
  • St. Joseph Health Santa Rosa, California, United States
View all 16 locations
View Trial Details
Completed

ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer

NCT03950570

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UCLA Health Burbank Specialty Care Burbank, California, United States
  • UCLA Health Laguna Hills Cancer Care Laguna Hills, California, United States
View all 20 locations
View Trial Details
Completed

Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

NCT06525675

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Onkologická klinika Fakultní nemocnice Olomouc Olomouc, Czechia
  • General University Hospital in Prague Prague, Czechia
  • Hopital Tenon Paris, France
  • Hospital Europeo Georges Pompidou AP-HP Paris, France
View all 36 locations
View Trial Details
Completed

Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer

NCT02491983

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • MedSIR investigative site Olomouc, Czechia
  • MedSIR investigative site Prague, Czechia
  • MedSIR investigative site Prague, Czechia
  • MedSIR investigative site Paris, France
View all 48 locations
View Trial Details
Completed

Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer

NCT02632045

Conditions
Breast Carcinoma, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
  • Northside Hospital, Inc. Atlanta, Georgia, United States
  • Northwestern Medical Hospital Chicago, Illinois, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
View all 13 locations
View Trial Details

Related conditions